Monika Tornsen
Director/Board Member bij IMMUNIC, INC.
Profiel
Monika Maria Tornsen is an Independent Director at Immunic, Inc. and President-North America at Calliditas Therapeutics AB.
She was previously Senior Vice President & General Manager-US at Sarepta Therapeutics, Inc., Vice President-Global Therapeutic at Genzyme Corp., and Chief Commercial Officer at Passage Bio, Inc. Tornsen is a graduate of the University of Lund.
Actieve functies van Monika Tornsen
| Bedrijven | Functie | Begin |
|---|---|---|
| IMMUNIC, INC. | Director/Board Member | 05-07-2022 |
| CALLIDITAS THERAPEUTICS AB | Corporate Officer/Principal | 07-01-2024 |
Eerdere bekende functies van Monika Tornsen
| Bedrijven | Functie | Einde |
|---|---|---|
| PASSAGE BIO, INC. | Corporate Officer/Principal | 01-12-2022 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01-01-2021 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-01-2019 |
Opleiding van Monika Tornsen
| University of Lund | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| CALLIDITAS THERAPEUTICS AB | Health Technology |
| PASSAGE BIO, INC. | Health Technology |
| IMMUNIC, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
